Cargando…
Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade
Cisplatin-based chemotherapy causes intestinal mucositis, which causes patients immense suffering and hinders the process of cancer treatment. Dioscin is a natural steroid saponin that exhibits strong anti-inflammatory and immunomodulatory properties. Herein, we investigate the protective effect of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025408/ https://www.ncbi.nlm.nih.gov/pubmed/35457248 http://dx.doi.org/10.3390/ijms23084431 |
_version_ | 1784690864013967360 |
---|---|
author | Jin, Shengzi Guan, Tongxu Wang, Shuang Hu, Mengxin Liu, Xingyao Huang, Siqi Liu, Yun |
author_facet | Jin, Shengzi Guan, Tongxu Wang, Shuang Hu, Mengxin Liu, Xingyao Huang, Siqi Liu, Yun |
author_sort | Jin, Shengzi |
collection | PubMed |
description | Cisplatin-based chemotherapy causes intestinal mucositis, which causes patients immense suffering and hinders the process of cancer treatment. Dioscin is a natural steroid saponin that exhibits strong anti-inflammatory and immunomodulatory properties. Herein, we investigate the protective effect of dioscin on cisplatin induced mucositis in rats from the perspective of gut microbiota and intestinal barrier. We established a rat model of intestinal mucositis by tail vein injection of cisplatin, and concurrently treated with dioscin oral administration. Parameters, such as body weight, diarrheal incidence, and D-Lactate levels, were assessed in order to evaluate the effects of dioscin on intestinal mucositis in rats. Furthermore, biological samples were collected for microscopic gut microbiota, intestinal integrity, and immune inflammation analyses to elucidate the protective mechanisms of dioscin on intestinal mucositis. The results revealed that administration of dioscin significantly attenuated clinical manifestations, histological injury and inflammation in mucositis rats. Besides this, dioscin markedly inhibited the gut microbiota dysbiosis induced by cisplatin. Meanwhile, dioscin partially alleviated junctions between ileum epithelial cells and increased mucus secretion. Moreover, dioscin effectively inhibited the TLR4-MyD88-NF-κB signal transduction pathway and reduced the secretion of subsequent inflammatory mediators. These results suggested that dioscin effectively attenuated cisplatin-induced mucositis in part by modulating the gut microflora profile, maintaining ileum integrity and inhibiting the inflammatory response through the TLR4-MyD88-NF-κB pathway. |
format | Online Article Text |
id | pubmed-9025408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90254082022-04-23 Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade Jin, Shengzi Guan, Tongxu Wang, Shuang Hu, Mengxin Liu, Xingyao Huang, Siqi Liu, Yun Int J Mol Sci Article Cisplatin-based chemotherapy causes intestinal mucositis, which causes patients immense suffering and hinders the process of cancer treatment. Dioscin is a natural steroid saponin that exhibits strong anti-inflammatory and immunomodulatory properties. Herein, we investigate the protective effect of dioscin on cisplatin induced mucositis in rats from the perspective of gut microbiota and intestinal barrier. We established a rat model of intestinal mucositis by tail vein injection of cisplatin, and concurrently treated with dioscin oral administration. Parameters, such as body weight, diarrheal incidence, and D-Lactate levels, were assessed in order to evaluate the effects of dioscin on intestinal mucositis in rats. Furthermore, biological samples were collected for microscopic gut microbiota, intestinal integrity, and immune inflammation analyses to elucidate the protective mechanisms of dioscin on intestinal mucositis. The results revealed that administration of dioscin significantly attenuated clinical manifestations, histological injury and inflammation in mucositis rats. Besides this, dioscin markedly inhibited the gut microbiota dysbiosis induced by cisplatin. Meanwhile, dioscin partially alleviated junctions between ileum epithelial cells and increased mucus secretion. Moreover, dioscin effectively inhibited the TLR4-MyD88-NF-κB signal transduction pathway and reduced the secretion of subsequent inflammatory mediators. These results suggested that dioscin effectively attenuated cisplatin-induced mucositis in part by modulating the gut microflora profile, maintaining ileum integrity and inhibiting the inflammatory response through the TLR4-MyD88-NF-κB pathway. MDPI 2022-04-17 /pmc/articles/PMC9025408/ /pubmed/35457248 http://dx.doi.org/10.3390/ijms23084431 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jin, Shengzi Guan, Tongxu Wang, Shuang Hu, Mengxin Liu, Xingyao Huang, Siqi Liu, Yun Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade |
title | Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade |
title_full | Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade |
title_fullStr | Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade |
title_full_unstemmed | Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade |
title_short | Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade |
title_sort | dioscin alleviates cisplatin-induced mucositis in rats by modulating gut microbiota, enhancing intestinal barrier function and attenuating tlr4/nf-κb signaling cascade |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025408/ https://www.ncbi.nlm.nih.gov/pubmed/35457248 http://dx.doi.org/10.3390/ijms23084431 |
work_keys_str_mv | AT jinshengzi dioscinalleviatescisplatininducedmucositisinratsbymodulatinggutmicrobiotaenhancingintestinalbarrierfunctionandattenuatingtlr4nfkbsignalingcascade AT guantongxu dioscinalleviatescisplatininducedmucositisinratsbymodulatinggutmicrobiotaenhancingintestinalbarrierfunctionandattenuatingtlr4nfkbsignalingcascade AT wangshuang dioscinalleviatescisplatininducedmucositisinratsbymodulatinggutmicrobiotaenhancingintestinalbarrierfunctionandattenuatingtlr4nfkbsignalingcascade AT humengxin dioscinalleviatescisplatininducedmucositisinratsbymodulatinggutmicrobiotaenhancingintestinalbarrierfunctionandattenuatingtlr4nfkbsignalingcascade AT liuxingyao dioscinalleviatescisplatininducedmucositisinratsbymodulatinggutmicrobiotaenhancingintestinalbarrierfunctionandattenuatingtlr4nfkbsignalingcascade AT huangsiqi dioscinalleviatescisplatininducedmucositisinratsbymodulatinggutmicrobiotaenhancingintestinalbarrierfunctionandattenuatingtlr4nfkbsignalingcascade AT liuyun dioscinalleviatescisplatininducedmucositisinratsbymodulatinggutmicrobiotaenhancingintestinalbarrierfunctionandattenuatingtlr4nfkbsignalingcascade |